Unpredictable and politically driven regulatory approaches cultivate an environment of enormous uncertainty for vaccine ...

A single-center study supported recommendations to lower the colorectal cancer screening age from 50 to 45. A single-center ...

The FDA approved treprostinil (Yutrepia) inhalation powder for pulmonary arterial hypertension and pulmonary hypertension ...

Nearly 5 million Americans with diabetes would qualify to use a GLP-1 receptor agonist for primary stroke prevention but few ...

Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

CHICAGO -- Neoadjuvant osimertinib (Tagrisso) with or without chemotherapy significantly increased major pathologic response ...

Selumetinib is currently FDA approved for children 2 years and older with symptomatic and inoperable plexiform neurofibromas.

Rose Hayes, RN, BSN, MA, is a nurse and a writer who helps scientists and clinicians to share their work with the public. Her ...

CHICAGO -- Neoadjuvant nivolumab (Opdivo) plus chemotherapy significantly improved overall survival (OS) compared with ...

The FDA launched a generative artificial intelligence tool designed to help employees, such as scientific reviewers and ...